Fundraising Fox
Tokyo · Seed–Series A · 36 people tracked
Also known as Beyond Next Ventures株式会社
Find your way into Beyond Next Ventures
Sign up to see every warm intro you have to Beyond Next Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Beyond Next Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Beyond Next Ventures backs 'exceptional challengers' building deep-tech companies, typically making its first investment at the seed stage. The firm focuses on bringing promising research from academia and large corporations to market, spanning healthcare, climate, agri-food and AI. Beyond funding, it provides incubation support including executive matching, team building, business plan development, grant-funding assistance, and access to wet lab facilities for spin-outs, carve-outs and solo entrepreneurs. It has invested in Japan since 2014 and expanded into India in 2019, applying over a decade of deep-tech investing and ecosystem-building experience to support founders from lab to market.
Source: firm website, verified Sep 27, 2026.
Team · 36 people
from the firm's website & curated
Tsuyoshi Ito founded Beyond Next Ventures in 2014 with the goal of returning financial gains to academia and supporting the deep-tech startup ecosystem. He previously joined JAFCO in 2003, where he led investments in university spin-offs, and currently serves as an outside director for portfolio companies and as a Visiting Professor at Nagoya and Hiroshima Universities. He holds a Master's in Chemical Engineering from Tokyo Institute of Technology.
Akito Arima joined Beyond Next Ventures in 2019, where he invests in Agri-FoodTech, bio-manufacturing, and climate tech. He was named Partner in 2022 and Head of the Open Innovation Department in 2025, and founded the TECHNIUM Global Conference. He serves as Project Manager for the MAFF SBIR program and Representative Director of Next Prime Food, previously worked in the Grain Division at Marubeni Corporation, and holds a degree in Biosciences and Informatics from Keio University.
Jay Krishnan is an entrepreneur and investor with a background in hardware platforms, networking, and IoT, spanning engineering, product management, and strategy across India, the US, and Canada. He was CEO of Canada's Accelerator Centre and founding CEO of India's T-Hub, and worked as a venture partner at SRI Capital and Mantra Capital, covering investments from pre-seed to Series A. His earlier career included roles at Brooktrout-Cantata, Juniper Networks, and Cisco Systems, and he exited DDI and Radifinity Inc. through IP and asset sales. He is also a published author.
Katsuya Hashizume is a Partner and Head of the Investment Department at Beyond Next Ventures, where he has led investment strategy since 2022. He joined the firm in 2020 and brings more than 15 years of experience nurturing academic ventures, supporting startups from pre-seed through commercialization and growth. His earlier career includes a Group Leader role at JAFCO and work as a representative promoter for JST START, and he holds a Master's degree from Keio University.
Kengo Ueha has more than 20 years of experience in venture capital. He joined Beyond Next Ventures as a Co-Founding Partner in 2015 and became Managing Director in 2023, where he oversees fund management, corporate operations, and the firm's investment activities. He previously worked at JAFCO starting in 2003, handling investment execution and finance/administrative operations, and holds a Bachelor of Laws from Chuo University.
Hiroyuki Kageyama joined Beyond Next Ventures in August 2023 as a venture capitalist focused on bridging science and its application in society. Before that, he worked at Accenture from 2020 as a strategy consultant on new business development projects for clients in the telecommunications and financial industries. He holds a graduate degree from the Graduate School of Science at The University of Tokyo, where his research covered ultrafast vibrational dynamics of molecules under intense laser fields using femtosecond laser equipment.
Keigo Yato holds a Ph.D. and previously conducted research on hepatitis vaccines and viral immune response at the National Institute of Infectious Diseases. He joined Beyond Next Ventures as a student intern during his doctoral studies and became a full-time employee in April 2022, where he focuses on investments in biotechnology and drug discovery.
Masahiro Goto joined Beyond Next Ventures in April 2024, where he focuses on investing in the climate tech sector, with an interest in clean and domestic energy in Japan. He began his career at Toyota Tsusho Corporation in April 2013 trading automotive chemical materials, later working on materials engineering at Toyota Motor Corporation and hydrogen projects in Shanghai, before joining Mitsubishi UFJ Capital in January 2022 to invest in startups with a focus on deep tech. He holds a master's degree in engineering from the Graduate School of Pure and Applied Sciences at the University of Tsukuba.
Yuichiro Sano joined Beyond Next Ventures in 2021 and leads the firm's India Investment Team, focusing on investments in Indian startups and the firm's global impact investing strategy. He previously spent over 15 years working in emerging markets at JBIC and JICA, including three years in India managing financial projects across debt and equity and starting startup investment programs. He holds a Bachelor's degree from Waseda University and a Master in Public Policy from Harvard Kennedy School.
Akiko Fujii studied supply chain management and customer satisfaction at university and holds a Master's degree in Industrial Engineering and Management from Tokyo Institute of Technology. In April 2021 she joined SMBC Nikko Securities' Investment Banking Division, supporting M&A and fundraising execution primarily for financial institutions. She joined Beyond Next Ventures as a venture capitalist in December 2024.
Former Executive Vice President of Kobayashi Pharmaceutical with over 40 years in medical device manufacturing and sales in Japan and the US.
Founder/President of Anioplex, LLC; a biopharma executive, scientist, and patent/corporate attorney, formerly a USPTO pharmaceutical patent examiner and researcher at Harvard, Kyoto University, and UCLA.
Representative of SubTonic Consulting with an MBA from the University of Chicago and cross-industry experience spanning medtech, steel, wine, and software.
Karthik Varada works on new investments in Indian startups and supports the growth and impact visibility of portfolio companies at Beyond Next Ventures. He previously was a postdoctoral researcher at the University of Tokyo studying ESG and climate-tech investments, and was a founding member of the Sasakawa Peace Foundation's Asia Women Impact Fund, an impact fund focused on gender equality. He holds a PhD and a master's degree from the University of Tokyo, and an undergraduate engineering degree from IIT Hyderabad.
CEO of FOODBOX Co., Ltd., providing consulting in food and agriculture to companies, local governments, and farmers.
Assistant Professor at Tokyo Jikei University and former PMDA medical device reviewer, researching medical IT and devices and advising ventures.
Founder of the Japan Biodesign Association, former Chairman of Terumo Corporation, and CEO of Art Management Shimanami LLC.
Mana Yada graduated from ICU and began her career at a recruitment agency, working on career transition support for professional services roles and corporate executive positions. Over her career she supported roughly 50 client companies and more than 900 candidates, served as a guest lecturer at a university, handled internal recruiting, and worked as a Director leading her own team. She later earned an MBA from ESADE Business School before joining Beyond Next Ventures, where she works in the HR Strategy Group.
Associate Professor at Kyoto University's Society-Academia Collaboration for Innovation, former McKinsey consultant, co-founder of GRA&GREEN, and a Forbes Asia 30 Under 30 honoree.
Masaya Eshita is an Executive Officer and Head of the Fund & Corporate Division at Beyond Next Ventures, where he oversees fund administration, finance and accounting, HR, general affairs, and public relations, and manages the firm's Beyond BioLAB TOKYO shared wet-lab facility. He joined the firm in 2020 and was appointed Executive Officer in 2026. He previously worked at LEVEL-5 Inc. starting in 2011 and at Recruit Career (now Indeed Recruit Partners) from 2018, and holds a B.A. in Economics and Business Administration from Kyushu University.
A physician with over 10 years in medical devices and drug development, including four and a half years as a reviewer at Japan's PMDA, now working in clinical development consulting.
Auditor at MIRAI NIHON VENTURES and former Deputy Head of Corporate Clients at SMBC Nikko Securities with 26 years of IPO and startup support experience.
Miyu Yamamoto joined Beyond Next Ventures in November 2023, working on open innovation and acceleration with a focus on supporting academic research funding in Japan. She previously worked at Nomura Research Institute on industry-academia-government collaboration, startup support, and new venture development in the medical and energy sectors, and held a part-time role at the R&D startup BIOTA doing research, grant management, and recruiting. She completed graduate studies in the Department of Earth and Planetary Environmental Science at the University of Tokyo.
CEO of Medical Lab Partners Corporation with 17 years of medical device development experience at Terumo, now consulting on medical device development.
Seiichi Saito began his career at Maruha Nichiro and later worked at the Australian Embassy in Japan before joining the JAFCO Group in 1998. From 2008 he worked on Fund of Funds formation and investment operations at AI Capital, and in 2014 became a Director at Rothschild & Co, managing European private equity funds with investors across Japan and Asia. He joined Beyond Next Ventures in April 2023, where his role focuses on investor relations. He holds an Economics degree from Sophia University, Tokyo, and an MBA from Warwick Business School in the UK.
A Medicinal Creation Advisor and Representative Director; co-founder of RaQualia Pharma and AskAt, and a professor at Chiba University Graduate School of Medicine.
Shota Sagiyama joined Beyond Next Ventures in 2017, where he focuses on executive search and team building for deep-tech startups, helping recruit co-founders and CXOs. He leads the firm's INNOVATION LEADERS PROGRAM, which has produced over 50 startup executives and supported 300+ strategic hires for portfolio companies. He is a certified Career Development Advisor and Career Consultant, and previously built a management talent practice for university ventures at Tokio Marine Nichido Career Service starting in 2007, after joining Quick Co., Ltd. in 2002.
Representative Partner at EDiX Professional Group / Edogawa Certified Public Accountant Office. A certified public accountant who has helped many startups, including life science and IT companies, go public and advises on innovation policy.
Takehiko Sawabe leads Beyond Next Ventures' investments in biotech start-ups. He previously served as Managing Director at INCJ, backing biotech companies including Stella Pharma, Megakaryon, and Scohia Pharma, and earlier held roles at Meiji Seika (as a medicinal chemist and later in business development), Johnson & Johnson (medical device business development), and AbbVie (Japan portfolio management). He holds a Master's degree from the University of Tokyo's Graduate School of Pharmaceutical Sciences and an MBA from GLOBIS University.
Affiliated with the Kawasaki Institute of Industrial Promotion, with drug discovery and regenerative medicine experience at Mitsubishi Tanabe and Takeda Pharmaceutical.
Yasutaka Kashiwagi trained clinically at Jikei University Kashiwa Hospital before working at the global consulting firm ZS Associates, where he supported new business development strategy, pricing, and product evaluation for pharmaceutical and medical device companies. He joined Beyond Next Ventures in 2025 to focus on investments in medical devices and digital health. He holds an M.D. from Jikei University School of Medicine.
A patent attorney and IP strategist with a background at Astellas Pharma, undefeated in IP litigation, and a specially appointed professor at Tohoku University.
Founder mafia
3 people who came through Beyond Next Ventures went on to found or lead other companies.
What they invest in
from 54 of 91 portfolio companiesHealthtech ×24Medical Devices ×23Deep Tech ×17AI & Machine Learning ×16Digital Health ×14Hardware ×13Biotech ×11SaaS ×8
HQs:Japan×37India×8United States×5Singapore×1
Who they back
founder profiles across 28 portfolio companiesFounding team size:solo founder×122 founders×103 founders×44+ founders×2
Where their founders studiedfrom 16 founders with education data
Indian Institute of Technology, Madras ×2Tohoku University ×2
What their founders studiedfrom 18 founders with field-of-study data
Engineering ×6Business & Management ×3Finance & Accounting ×2Medicine ×2
Investments · 91 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 22024 · 22023 · 32022 · 22021 · 22020 · 42019 · 12018 · 119 dated
Cytoronix develops cell-observation technology using CMOS image sensors, a technology originally started at Toshiba's R&D Center.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSemiconductorsYokohama, JP
Neautech operates an online medical beauty treatment platform (ANS.) that connects patients with doctors for skin concerns, develops functional cosmetics based on diagnostic data, and builds healthcare technology infrastructure including AI systems co-developed with Panasonic.
ConsumerDigital HealthHealthtechMedical DevicesTokyo, JP
Akihiro Mizumoto(CEO)Shirika Murayama(Director / ANS. Business Division Head / Physician)Yuko Kanazawa(Director / Medical Platform Business Division Head)
Co-investorsDEEPCORE Inc.
Visban develops continuous millimeter-wave (mmWave) coverage technology to enable real-world deployment of wireless networks.
AI & Machine LearningDeep TechHardwareTokyo, JP
S.B. Cha(CEO/Co-Founder)Ryosuke Kuwada(Chief Business Officer/Co-Founder)Arokia Nathan(Chief Science Officer/Co-Founder/Director)in
Co-investorsUTokyo Innovation Platform Co. Ltd.
Aillis is a Japanese healthcare technology company developing medical devices and technology aimed at making medical expertise more widely shared and accessible.
AI & Machine LearningHealthtechMedical Devices
Sho Okiyama(Founder)in
Co-investorsFunds Startupsi-nest capitalSTRIVEZ Venture CapitalAozora Corporate InvestmentPegasus Tech Ventures
.png){kind=logo}
Alchemedicine is a drug discovery company focused on research and development of new small-molecule medicines, using its proprietary synthesis technology HiSAP® to improve on existing drugs' weak efficacy, side effects, and pharmacokinetics.
BiotechDeep Tech
Co-investorsJAFCO Group
Anaut develops medical devices for surgical support using artificial intelligence and advanced technology to enhance surgeon capabilities and patient safety during surgical procedures.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
Nao Kobayashi(Representative Director (代表取締役))Kensuke Hosomi(Director (取締役))
Co-investorsG-STARTUPVision Incubate
ARK is a land-based aquaculture company that recreates marine environments on land to raise various organisms using controlled water, air, soil, and heat systems.
AgTechCircular EconomyClimate TechFoodTechHardwareChigasaki, JP
Takao Takenosita(Co-founder, Chief Sustainability Officer)Yoshida(Co-founder, Chief Aqua Officer)Yosuke Yoshida(Co-founder, Representative)Takenosita(Co-founder, Chief Sustainability Officer)Gishin Nakamura(Co-founder, CEO)
Co-investorsUntroD CapitalW Inc.Tether
AssetHub is an AI-powered 3D character creation platform that converts concept images into modular, editable 3D assets with automatically named and separated components.
AI & Machine LearningCreator EconomyGamingSan Francisco, US
Takuya Goto(Founder)in
Co-investorsBrincProgressionTechstarsArchetype VenturesCRCM VenturesMitsui Sumitomo Insurance Capital
Co-investorsAnkur Capital
Biomoneta develops air decontamination devices that use ZeBox technology to eliminate airborne pathogens and provide medical-grade sterility without ozone or harmful radiation.
BiotechHardwareHealthtechMedical DevicesBangalore, IN
Janani Venkatraman(Co-founder & Director)inSantanu(Co-founder & Director)Arindam(Co-founder & Chief Executive Officer)
Co-investorsMalpani Ventures
Bolt Medical develops the Bolt IVL intravascular lithotripsy system, a laser-based balloon catheter platform that fractures arterial calcium using acoustic pressure waves to treat coronary and peripheral artery disease.
HardwareHealthtechMedical DevicesMarlborough, US
Co-investorsLongitude Capital
The company develops non-cathartic virtual colonoscopy technology to enable early detection of colorectal cancer, which ranks first in cancer incidence and second in cancer mortality in Japan.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsGlobal BrainJIC Venture Growth Investments
CureApp HT is a smartphone application that helps patients manage hypertension through self-monitoring of blood pressure and lifestyle changes, with supporting guidance from physicians.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
Kohta Satake, MD, MPH, MBA(Founder)in
Co-investorsKeio Innovation InitiativeSaisei Ventures
India's leading digital healthcare platform, which closed a $40M Series B round.
Satish Kannan(Founder)inEnbasekar D(Founder)inEnbasekar Dinadayalane(Founder)
Co-investorsBessemer Venture PartnersFinSight VenturesGSF AcceleratorPowerhouse VenturesRebright PartnersInnoVen Capital
EF Polymer makes a 100% natural super-absorbent polymer produced by upcycling agricultural waste such as fruit peels and pulp.
AgTechCircular EconomyNew MaterialsOnna Village, Okinawa, JP
Narayan Lal Gurjar(Founder / CEO)inAnkit Jain(Co-founder, Chief Business Development Officer (CBDO))inPuran Rajput(Co-Founder / Chief Operating Officer (COO))in
Co-investorsLifetime VenturesSVG Ventures | THRIVEUniversal Materials Incubator
Ecumenopolis develops a conversational AI agent platform that deploys agents across education and work settings to support learning, productivity, and creativity.
AI & Machine LearningEdTechSaaSTokyo, JP
Keita Miyamura(Founder)
Co-investorsG-STARTUPShizuoka Capital
FaunaTech develops handheld diagnostics tools for testing food quality and animal health biomarkers at point-of-use in agricultural settings.
AgTechFoodTechHardwareHealthtechBangalore, IN
FinalLayer is an AI-powered LinkedIn post generator that helps creators, founders, and professionals create personalized viral content in minutes.
AI & Machine LearningCreator EconomyMarketing TechSaaS
Vidya(Co-founder)Lakshminath(Co-founder)
Co-investorsFjor Founders
FullDepth develops and manufactures industrial underwater drones (autonomous vehicles) for inspection and survey operations in marine and subsea environments.
Deep TechHardwareRoboticsTokyo, JP
Shohei Ito(Director (formerly Representative Director & CEO))Satoshi Yoshiga(Representative Director & CEO)
Co-investorsDRONE FUNDZENRIN FUTURE PARTNERS
Gojo & Company is a Japan-based financial inclusion group that invests in and operates microfinance institutions, banks, and fintech companies across Asia and Africa to expand access to financial services for underserved clients.
Enterprise SoftwareFintechImpact & Social GoodSaaSTokyo, JP
Taejun Shin(Co-founder, Managing Partner & CEO)Sanjay Gandhi(Co-founder & CIO)inArnaud Ventura(Managing Partner)Kohei Katada(Managing Partner / CFO)Gurol Michael Sari(Chief Operating Officer)Takao Takahashi(Chief People & Inclusion Officer)in
Co-investors15th RockDIMENSIONFujitsu VenturesGlobis Capital PartnersGMO VenturePartnersHakuhodo DY Ventures+6 more
GraGreen develops improved crop varieties using genome editing and traditional breeding methods to reduce resource inputs and increase agricultural yields.
AgTechClimate TechNagoya, JP
Masaki Niwain
Co-investorsKyoto University Innovation CapitalSeiho Investment WorksShizuoka CapitalTechstarsUTokyo Innovation Platform Co. Ltd.
GroMo is a platform that enables individuals to earn income by selling financial products from partner brands within their networks.
B2B MarketplacesFintechInsurTechMarketing TechSaaSGurugram, IN
Ankit Khandelwal(Founder)inDarpan Khurana(Founder)inSneha Singh(Recruitment Manager)Bhaumik Jain(Head of Product)
Co-investorsFirst ChequeKube VCRebel FundSoma CapitalTracxn labsVentureSouq+14 more
HITOTSU develops digital transformation software for hospitals and healthcare providers, including communication tools, messaging platforms, and incident reporting systems.
Digital HealthEnterprise SoftwareSaaSTokyo, JP
佐藤 公彦(代表取締役)
Co-investorsAngel Bridge Co.,Ltd.
.JPN.COM is a domain registry offering .jpn.com domains as an alternative to traditional Japanese ccTLDs, providing unrestricted global access to Japan-focused digital presence without residency or business registration requirements.
Sector AgnosticLas Vegas, US
Co-investorsGlobal BrainSumitomo Mitsui Finance and LeasingIncubate FundIncubate Fund
Technology-enabled integrated healthcare financing platform spanning crowdfunding, healthcare lending, and health insurance distribution.
Khushboo Jain(Founder)inPiyush Jain(Founder)in
Co-investorsHealthQuadShorooq Partners
IntegriCulture is a Japanese cellular agriculture company developing cell-culture systems and production technology for cultured foods, along with OEM/ODM cosmetics and supplements and sales of cell-culture consumables and equipment.
BiotechDeep TechFoodTechFujisawa, JP
Yuki Hanyu(代表取締役 (CEO))in
Co-investorsHakuhodo DY VenturesHiroshima Venture Capital Co. Ltd.Iyogin CapitalSpiral CapitalAgFunderVU Venture Partners
Yuki Hanyu(Founder)in
Co-investorsUntroD CapitalVU Venture PartnersAgFunder
Kanjin Therapeutics is a biotechnology startup developing treatments to restore kidney function and address chronic kidney diseases, using a strategy of targeting the liver.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsKyoto University Innovation Capital
Operates recruitment and career services connecting STEM students, researchers, and engineers with companies, including scout services, online career events, and specialized support for PhDs and postdocs.
B2B MarketplacesHR TechTokyo, JP
Co-investorsDnx VenturesCyberAgent Capital
Lil Goodness makes chocolate using single-origin, organic cacao beans sourced from Ghana and Ecuador, produced through a "bean to bar at source" process in India.
ConsumerDirect to ConsumerFoodTech
MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use.
BiotechDeep TechHealthtech
Co-investorsAxil CapitalLong Black Partners
Medfin helps patients in India access surgical care by connecting them with a network of doctors and hospitals, managing health insurance processing, and offering no-cost EMI financing for procedures.
Digital HealthFintechHealthtech
Arjun Kumar(Founder)in
Co-investorsAxilor VenturesHealthXCapitalSony Ventures Corporation
Metcela is a Japanese biotech company developing science-backed therapies for pediatric and rare diseases, with in-house capabilities spanning research through development.
BiotechHealthtechMedical Devices
Co-investorsF-Prime CapitalOSAKA University Venture CapitalSony Ventures CorporationTOHOKU University Venture PartnersUTEC
Myelin Foundry develops edge AI solutions for automotive, industrial, and media applications, including in-car assistants, smart factory inspection systems, and video enhancement tools.
AI & Machine LearningDeep TechBangalore, IN
Co-investorsEndiya PartnersAxilor Ventures
Myelin is an industry-agnostic venture capital firm that invests in founders from seed through Series A.
Sector Agnostic
Co-investorsJazzya InvestmentsVNV GlobalVostok New VenturesEndiya PartnersSIDBI Venture Capital
Myoridge develops serum-free cell culture media and optimization services for cell cultivation and regenerative medicine applications.
BiotechHealthtechMedical DevicesJapan, JP
Co-investorsDiamond Edge VenturesKyoto University Innovation Capital
N.B.
AI & Machine LearningHealthtechMedical DevicesTokyo, JP
Kazuya Shobayashi(President & CEO)
OPExPARK uses IoT technology to digitize operating rooms and standardize surgical practices globally.
Digital HealthHealthtechIoTMedical DevicesTokyo, JP
本田泰教(代表取締役 (Representative Director))
A technology company that develops avatar robots and communication tools to enable people with physical disabilities and mobility constraints to participate in society and work remotely.
AI & Machine LearningFuture of WorkHardwareHealthtechHR TechMedical DevicesRoboticsTokyo, JP
Kentaro Yoshifuji(Co-founder, Representative Director, CVO)Yoshifumi Shiiba(Co-founder, Director CTO)
Co-investorsUntroD Capital
QD Laser develops, manufactures, and sells high-efficiency semiconductor lasers for telecommunications and industrial use, as well as visual-information devices.
Deep TechHardwareMedical DevicesSemiconductorsYokohama, JP
Mitsuru Sugawara(Founder)in菅原 充(Founder & Chief Technology Advisor)大久保 潔(President & Representative Director)
Co-investorsDG Ventures, Inc.MIRAI SOUZOUMitsui Global InvestmentNTT DOCOMO VenturesOita Venture CapitalSMBC Venture Capital+5 more
Red Arrow Therapeutics develops cancer therapies using a proprietary nanopolymer drug-delivery system for programmable encapsulation and release of biologics such as peptides, antibodies, and proteins.
BiotechHealthtechMedical DevicesCambridge, US
Horacio Cabral(Scientific Founder / Technology Pioneer)Philipp Steiner(Chief Scientific Officer (CSO))
Co-investorsKeio Innovation InitiativeOSAKA University Venture CapitalUTEC
SUSMED (サスメド株式会社) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
上野 太郎(代表取締役社長)Taro Ueno, M.D., Ph.D(Founder)in本橋 智光(取締役 CTO)
PartnerKengo Ueha· led
Co-investorsDIMENSIONSony Ventures CorporationTOHOKU University Venture Partners
Koji Itoin
Co-investorsEnergy & Environment InvestmentGlobal BrainKyoto University Innovation Capital
TruDoc provides chronic disease management and telehealth services, offering round-the-clock access to medical care, symptom checking, emotional health support, and personalized health metrics.
Digital HealthHealthtech
Abhishek Shah(President)inAsad Khan(CEO)inVish Narain(Executive Chairman)inUtsaav Pathak(Group Finance Director)in
Co-investorsGSF Accelerator
Umami United develops shelf-stable, plant-based egg replacement ingredients for food manufacturers, including a binder product for industrial baking that provides binding, water retention, and shape retention.
FoodTechTokyo, JP
Hiroto Yamazaki(Founder)in
Co-investorsBig Idea VenturesGenesia Venturesmint VC
Universal Brain develops a neuroscience-based platform that uses an EEG wearable and a digital ERP (event-related potential) interface to measure brain function and group patients into "neurotypes" for psychiatric conditions, starting with depression.
Digital HealthMedical DevicesMental Health
Kazu Okuda, MD(Founder)in
Volt14 Solutions develops silicon-majority anode materials that replace conventional graphite anodes in lithium-ion battery cells, aiming to increase energy density and lower cost while remaining compatible with existing cell manufacturing infrastructure.
Advanced ManufacturingCleantechDeep TechEnergyNew MaterialsSaaSSingapore, SG
Animesh Jhar(Cofounder)inAdam Haldar(Cofounder)inAnimesh JhainArindam HaldarAnimesh Kumar Jha(Founder)in
Co-investors500 GlobalCocoon CapitalEntrepreneur FirstSupermorpheusThird DerivativeBlume Ventures
Shimizu Shinya(Founder)inSugimoto Masaaki(Founder)in
Co-investorsGlobal BrainShizuoka Capital
A Japanese company that selects underutilized fish species from Japan's over 4,000 varieties and uses advanced aquaculture technology to produce high-quality farmed fish for global markets.
AgTechFoodTech
Shunichiro Hosoya(Founder)in
Co-investorsGlobal BrainSpiral CapitalSpiral Innovation Partners
Fermelanta develops programmable fermentation and biomanufacturing platforms to produce rare natural molecules, offering an alternative to traditional plant extraction and petrochemical synthesis.
BiotechCleantechDeep Tech
Shogo Fukizaki(Founder)in
Co-investorsAngel Bridge Co.,Ltd.Keio Innovation InitiativeMiyako CapitalPlug and Play VenturesUniversal Materials Incubator
Rhinoflux is a Kyoto University-derived energy company that generates electricity from biomass without combustion, using an aqueous chemical reaction ("wet chemical looping") that also captures high-purity CO₂.
CleantechDeep TechEnergy
Atsushi Alex Mazawa(Founder)in
Co-investorsGlobal BrainKyoto University Innovation Capital
Riverfield develops surgical robotic systems that provide force feedback and control similar to human hands, enabling safer and more precise robot-assisted surgery.
AI & Machine LearningDeep TechHealthtechMedical DevicesRoboticsTokyo, JP
只野耕太郎Kota Tadano只野 耕太郎
Co-investorsHiroshima Venture Capital Co. Ltd.Japan Post Capital Co. Ltd.
Offers the 'Confidential AI Suite' security product brand centered on confidential computing to safely connect data and AI.
Ryosuke Takahashi(Founder)inTakeharu Kondo(Founder)
Co-investorsCentral Japan Innovation CapitalDG Daiwa VenturesFunds StartupsGlobis Capital Partners
BiPSEE develops VR- and AI-based mental health care programs, including VRx, a prescription-based digital therapeutic that delivers VR treatment programs under a physician's prescription.
AI & Machine LearningDigital HealthMental Health
Masayo Matsumura(Founder)in松村 雅代(Chief Executive Officer, MBA, MD)上木原 広平(Chief Operating Officer)小松 尚平(Chief Product Officer)
Co-investorsKyoto University Innovation CapitalOpen Network LabScrum Ventures
ElevationSpace develops small-satellite re-entry and recovery technology to return the results of in-orbit experiments to Earth, aiming to build an orbital transport network for people and goods.
Deep TechHardwareSpace Tech
Ryohei Kobayashi(Founder)inToshinori Kuwahara(Founder)
Co-investorsCanal VenturesGenesia VenturesGlobal BrainMIRAI SOUZOUNTT DOCOMO VenturesPERSOL VENTURE PARTNERS+4 more
KOALA Tech Inc. is a Kyushu University spinout commercializing organic semiconductor laser diode (OSLD) technology as laser light sources compatible with organic electronic device platforms, including OLED displays.
Deep TechHardwareSemiconductorsFukuoka, JP
安達千波矢(Founder (Kyushu University Professor))Chihaya Adachi(Co-founder (Kyushu University Professor))Fatima Bencheikh(Representative Director, CEO & CTO)in
Co-investorsKyoto University Innovation CapitalSony Ventures Corporation
LabBase is a Japanese company that operates recruitment and career services, with content indicating a focus on science and technology (STEM) talent.
EdTechHR TechMarketplacesSaaSTokyo, JP
Michiaki Kamo(代表取締役CEO (Representative Director & CEO))in
Co-investorsCyberAgent CapitalJIC Venture Growth InvestmentsPKSHA Technology Capital
Lifescapes develops brain-machine interface (BMI) technologies, including medical-grade and rehabilitation-focused devices for hand and finger control applications.
AI & Machine LearningDeep TechHealthtechMedical DevicesTokyo, JP
Junichi Ushiba(Chairman (Founder, BMI Developer))Masaaki Hayashi(Representative Director, CEO)in
Co-investorsKeio Innovation InitiativeX-HUB TOKYO Global Startup Accelerator
Photo Electron Soul develops and manufactures electron beam generation devices and components for research and industrial applications.
Advanced ManufacturingDeep TechHardwareSemiconductorsNagoya, JP
鈴木孝征(Representative Director (代表取締役))西谷智博(Director, Technology Development (取締役 技術開発担当))田村逸郎(Director, Management Planning (取締役 経営企画担当))土谷滋(Director, Business Operations (取締役 事業統括担当))
Co-investorsi-nest capitalJapan Post Capital Co. Ltd.Shizuoka Capital
Yaqumo develops neutral atom quantum computers designed to solve complex computational problems across materials, chemicals, pharmaceuticals, and finance sectors.
Deep TechHardwareQuantum ComputingTokyo, JP
Kazuhiro NakakojiKazuhiro Nakashoji(Founder)
Co-investorsAlumni VenturesJIC Venture Growth InvestmentsKyoto University Innovation CapitalQuantonation
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
㈱スコヒアファーマALYAqua TheonATOMEmiumGeneric AadhaarGigIndiaGourmet GardenI'mbesideyouK3RKoala TechLIFESCAPESMUSE DiagnosticsPhasorz TechnologyPRECISIONPremediRegional FishRepertoire Genesis株式会社RhinofluxSAKANA DreamSECAI MARCHESonoligoT.G.MedicalTOWINGПройти интервью株式会社GramEye
Portfolio news
latest coverage across their companiesImpactGuru · impactguru.com · Aug 9, 2026
GroMo · gromo.in · Jul 10, 2026
Biomoneta · biomoneta.com · Jan 6, 2026
EF Polymer · prnewswire.com · Sep 30, 2025
Frequently asked questions
- How many investments has Beyond Next Ventures made?
- Beyond Next Ventures has 91 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
- What stage does Beyond Next Ventures invest at?
- Beyond Next Ventures invests at the Seed, Series A stages.
- What sectors does Beyond Next Ventures focus on?
- Beyond Next Ventures focuses on AgTech, AI & Machine Learning, Biotech, Circular Economy, Climate Tech, Deep Tech, Digital Health, Fintech, FoodTech, Healthtech, Medical Devices, Quantum Computing, Robotics, Semiconductors, Space Tech.
- Where is Beyond Next Ventures located?
- Beyond Next Ventures is headquartered in Tokyo, JP.
- Does Beyond Next Ventures lead rounds?
- Yes, Beyond Next Ventures leads investment rounds.
- Who does Beyond Next Ventures co-invest with?
- Beyond Next Ventures most often shares deals with Kyoto University Innovation Capital, Global Brain, Keio Innovation Initiative, among 122 tracked co-investors.
- What size deals does Beyond Next Ventures back?
- Across 8 deals with disclosed amounts, Beyond Next Ventures has joined rounds of $1M – $19M (median $2M).
Images
Co-investors · 5
Z Venture Capital is the corporate venture arm of the LY Corporation Group, investing in and supporting innovative startups pursuing transformative societal change by leveraging the group's proprietary resources, expertise, and assets.
AgFunder is a venture capital firm focused on the agrifoodtech sector, and also publishes research such as its annual Global AgriFoodTech Investment Report.
VU Venture Partners is a global early-stage technology venture capital fund investing across the world's largest market opportunities, operating with a large investment team and six vertical-focused practices.
BEENEXT is a global venture firm built around a community of founders and investors, having backed around 180 companies across 17 countries and 5 continents.
An early-stage and growth-stage B2B venture capital firm investing across technology, fintech, and healthcare sectors with a founder-centric approach.
Firms observed investing alongside Beyond Next Ventures, from public investor directories. Shared companies are the overlap with Beyond Next Ventures's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Vesna is a deep-tech venture fund, described as the first Slovenian-Croatian deep tech fund, backed by the European Investment Fund, investing in early-stage technologies spun out of Slovenian and Croatian R&D institutions.
Qbic is an inter-university venture capital fund that backs the transformation of technological breakthroughs from its academic and research partners into sustainable businesses.